Increase the levothyroxine dose to bring TSH into the normal reference range
For this elderly female patient already on levothyroxine with TSH 7.28 mIU/L and normal free thyroid hormones, you should increase her levothyroxine dose. This represents inadequate replacement therapy in a patient with established overt hypothyroidism requiring treatment 1.
Clinical Reasoning
This patient has subclinical hypothyroidism in a treated hypothyroid individual, not a new diagnosis. The guidelines are explicit: when subclinical hypothyroidism occurs in levothyroxine-treated patients with overt hypothyroidism, the dosage should be adjusted to bring serum TSH into the reference range 1.
Key Distinction
This scenario differs fundamentally from treating de novo subclinical hypothyroidism in elderly patients. The patient is already on 100 mcg levothyroxine, indicating she has established hypothyroidism requiring treatment—her current dose is simply insufficient.
Dosing Strategy in Elderly Patients
Increase cautiously due to cardiovascular risk:
- Make small incremental adjustments (12.5-25 mcg increases)
- The rapidity of dose adjustment depends on age and cardiac comorbidities 1
- In elderly patients with cardiac disease, slower titration is essential to avoid precipitating cardiac ischemia or arrhythmias 2
Important Caveats
Before increasing the dose, verify:
- Medication adherence - Non-compliance is extremely common and the most frequent cause of elevated TSH in treated patients 1
- Timing of administration - Must be taken on empty stomach, 30-60 minutes before breakfast
- Drug interactions - Multiple medications impair levothyroxine absorption 3:
- Calcium, iron supplements, PPIs (take levothyroxine 4 hours apart)
- Estrogens, bile acid sequestrants, antacids
- Check her medication list carefully
Confirm the diagnosis:
- Repeat TSH in 6-8 weeks if this is a new finding to exclude transient elevation
- Ensure proper specimen collection (morning, fasting if possible)
Target TSH in Elderly Patients
While the guideline states TSH should be brought into the reference range, age-adjusted TSH targets are important 4, 5, 6:
- TSH naturally increases with aging
- Upper limit of normal is approximately 7.5 mIU/L for patients over age 80 5
- For this patient with TSH 7.28, treatment is still warranted given she's already on therapy
However, minimal TSH elevations may not require aggressive adjustment in elderly patients who feel well, particularly those with arrhythmias or cardiac disorders 1. If she is asymptomatic and has significant cardiac disease, a more conservative approach with close monitoring may be reasonable.
Monitoring After Dose Adjustment
- Recheck TSH in 6-8 weeks after any dose change
- Assess for symptoms of over-replacement (palpitations, tremor, weight loss, anxiety)
- Monitor for cardiac symptoms, especially angina or arrhythmias
- Avoid over-treatment: TSH suppression below normal increases cardiovascular and skeletal risks in elderly patients 4, 2
Special Consideration: TSH 7-10 Range
Recent evidence suggests that in elderly patients with untreated subclinical hypothyroidism, TSH 7.0-9.9 mIU/L is associated with increased cardiovascular mortality and stroke risk 4. This supports treatment in this TSH range. However, your patient is already being treated, so the goal remains normalization of TSH with her established therapy.